Body mass index adjusted prostate-specific antigen and its application for prostate cancer screening

Urology

Volumn 76, Issue 5, 2010, Pages 1268.e1-1268.e6

  Liang, Yuanyuan ^a,b,c   Ankerst, Donna P ^a,b,d   Sanchez, Michael ^e   Leach, Robin J ^a,b,f   Thompson, Ian M ^a  

^a University of Texas Health Science Center   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^f Department of Pediatrics ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BODY MASS; CANCER RISK; CANCER SCREENING; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER;

EID: 78149357541     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2010.04.060     Document Type: Article

References (28)

1. F.H. Schroder, R.C. van den Bergh, and T. Wolters Eleven-year outcome of patients with prostate cancers diagnosed during screening after initial negative sextant biopsies Eur Urol 57 2010 256 266
2. I.M. Thompson, D.K. Pauler, and P.J. Goodman Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter N Engl J Med 350 2004 2239 2246
3. I.M. Thompson, D.P. Ankerst, and C. Chi Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial J Natl Cancer Inst 98 2006 529 534
4. J.O. Ahn, and J.H. Ku Relationship between serum prostate-specific antigen levels and body mass index in healthy younger men Urology 68 2006 570 574
5. J. Baillargeon, B.H. Pollock, and A.R. Kristal The association of body mass index and prostate-specific antigen in a population-based study Cancer 103 2005 1092 1095
6. S. Culp, and M. Porter The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men BJU Int 104 2009 1457 1461
7. J.H. Han, I.H. Chang, and S.H. Ahn Association between serum prostate-specific antigen level, liver function tests and lipid profile in healthy men BJU Int 102 2008 1097 1101
8. J.H. Han, N.Y. Choi, and S.H. Bang Relationship between serum prostate-specific antigen levels and components of metabolic syndrome in healthy men Urology 72 2008 749 754
9. Y.J. Kim, B.K. Han, and S.K. Hong Body mass index influences prostate-specific antigen in men younger than 60 years of age Int J Urol 14 2007 1009 1012
10. A.R. Kristal, C. Chi, and C.M. Tangen Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase Cancer 106 2005 320 328
11. E.R. DeLong, D.M. DeLong, and D.L. Clarke-Pearson Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 44 1988 837 845
12. C. Rodriguez, A.V. Patel, and E.E. Calle Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States Cancer Epidemiol Biomarkers Prev 10 2001 345 353
13. S.J. Freedland, E.A. Platz, and J.C. Presti Jr. Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection J Urol 175 2006 500 504
14. L.L. Banez, R.J. Hamilton, and A.W. Partin Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer JAMA 298 2007 2275 2280
15. A. Rundle, and A.I. Neugut Obesity and screening PSA levels among men undergoing an annual physical exam Prostate 68 2008 373 380
16. R.L. Grubb 3rd, A. Black, G. Izmirlian, and T.P. Hickey Serum prostate-specific antigen hemodilution among obese men undergoing screening in the prostate, lung, Colorectal and Ovarian Cancer Screening Trial Cancer Epidemiol Biomarkers Prev 18 2009 748 751
17. S.O. Andersson, A. Wolk, and R. Bergstrom Body size and prostate cancer: a 20-year follow-up study among 135,006 Swedish construction workers J Natl Cancer Inst 89 1997 385 389
18. N.M. Aziz, T. Hartman, and M. Barrett Weight and prostate cancer in the alpha-tocopherol, beta-carotene cancer prevention (ATBC) trial Proc American Society For Clinical Oncology 19 2000 647a (abstract 2550)
19. A.G. Schuurman, R.A. Goldbohm, and E. Dorant Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study Am J Epidemiol 151 2000 541 549
20. C.L. Amling, R.H. Riffenburgh, and L. Sun Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy J Clin Oncol 22 2004 439 445
21. S.J. Freedland, W.J. Aronson, and C.J. Kane Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group J Clin Oncol 22 2004 446 453
22. S.J. Freedland, M.K. Terris, and J.C. Presti Jr. Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins J Urol 172 2004 520 524
23. W.W. Bassetta, M.R. Cooperberga, and N. Sadetskya Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE Urology 66 2005 1060 1065
24. N.J. Wald, A.K. Hackshaw, and C.D. Frost When can a risk factor be used as a worthwhile screening test? BMJ 319 1999 1562 1565
25. M.S. Pepe, H. Janes, and G. Longton Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker Am J Epidemiol 159 2004 882 890
26. J.H. Ware The limitations of risk factors as prognostic tools N Engl J Med 355 2006 2615 2617
27. J.H. Ware, and T. Cai Comments on 'Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond' by Pencina MJ, et al Statist. Med 27 2008 185 187
28. S. Loeb, X. Yu, and R.B. Nadler Does body mass index affect preoperative prostate specific antigen velocity or pathological outcome after radical prostatectomy? J Urol 177 2007 102 106